Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lakana Wongsrisang"'
Autor:
Nasamon Wanlapakorn, Nungruthai Suntronwong, Sitthichai Kanokudom, Suvichada Assawakosri, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Lakana Wongsrisang, Thanunrat Thongmee, Ratchadawan Aeemjinda, Nongkanok Khanarat, Donchida Srimuan, Thaksaporn Thatsanathorn, Ritthideach Yorsaeng, Apirat Katanyutanon, Wichai Thanasopon, Wichan Bhunyakitikorn, Chaninan Sonthichai, Piyada Angsuwatcharakorn, Withak Withaksabut, Jira Chansaenroj, Natthinee Sudhinaraset, Yong Poovorawan
Publikováno v:
Heliyon, Vol 10, Iss 21, Pp e39889- (2024)
Background: Limited data exists regarding population immunity against diphtheria, tetanus, and pertussis in Thailand during the post-COVID-19 pandemic period. This study aimed to evaluate the age-specific seroprevalence of anti-diphtheria toxoid (ant
Externí odkaz:
https://doaj.org/article/e2ef78d215f04422bcd189744d5e9cbc
Autor:
Jira Chansaenroj, Nungruthai Suntronwong, Sitthichai Kanokudom, Suvichada Assawakosri, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Lakana Wongsrisang, Thanunrat Thongmee, Ratchadawan Aeemjinda, Nongkanok Khanarat, Donchida Srimuan, Thaksaporn Thatsanathorn, Ritthideach Yorsaeng, Apirat Katanyutanon, Wichai Thanasopon, Wichan Bhunyakitikorn, Chaninan Sonthichai, Piyada Angsuwatcharakorn, Withak Withaksabut, Nasamon Wanlapakorn, Natthinee Sudhinaraset, Yong Poovorawan
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Seroprevalence studies on SARS-CoV-2 are essential for estimating actual prevalence rates of infection and vaccination in communities. This study evaluated infection rates based on total anti-nucleocapsid immunoglobulin (N) and/or infection
Externí odkaz:
https://doaj.org/article/fab07f2fe379451a9f68bc1846d5ff7b
Autor:
Jira Chansaenroj, Nungruthai Suntronwong, Sitthichai Kanokudom, Suvichada Assawakosri, Ritthideach Yorsaeng, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Lakana Wongsrisang, Donchida Srimuan, Thaksaporn Thatsanatorn, Thanunrat Thongmee, Chompoonut Auphimai, Pornjarim Nilyanimit, Nasamon Wanlapakorn, Natthinee Sudhinaraset, Yong Poovorawan
Publikováno v:
Vaccines, Vol 10, Iss 7, p 1071 (2022)
Coronavirus disease 2019 (COVID-19) booster vaccination is being comprehensively evaluated globally due to waning immunity and the emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. Therefore, this study aimed to
Externí odkaz:
https://doaj.org/article/0fb950a0af3945fda43d71c78e7cc4f5